GlassScriptPhysician profile
Barry J Gertz
NPI 1891954848
$903,187.01
in general payments reported to CMS, 2019-2025
3 companies · $119K in 2025
The $119K reported for 2025 was more than what 99% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139K · 2020: $137K · 2021: $148K · 2022: $99K · 2023: $171K · 2024: $90K · 2025: $119K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $380K · Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $379,724.00 |
| Food and Beverage | $119.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $900,792.87 | 2019-2025 | |
| Emd Serono, INC. | $2,275.00 | 2019 | |
| Merck Sharp & Dohme LLC | $119.14 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Gertz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.